Newsfeeds Archive - Page 55 of 19074

1 minute read

XBiotech Shares Results From Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment For Advanced Pancreatic Cancer

June 18, 11:48 AM

XBiotech (NASDAQ:XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Known as 1-BETTER, the study examined Natrunix

XBIT

2 minute read

Spotlight on Super Micro Computer: Analyzing the Surge in Options Activity

By Benzinga Insights

June 18, 11:46 AM

Financial giants have made a conspicuous bullish move on Super Micro Computer. Our analysis of options history for…

SMCI

3 minute read

Check Out What Whales Are Doing With NFLX

By Benzinga Insights

June 18, 11:46 AM

Investors with a lot of money to spend have taken a bearish stance on Netflix (NASDAQ:NFLX). And retail…

NFLX

2 minute read

The ‘AI Big 10’: 10 AI Stocks Now Comprise 28% Of The S&P, Up From 14% In 2023

By Hayden Buckfire

June 18, 11:45 AM

SPDR S&P 500 ETF has risen 30% in 8 months, thanks to AI stocks taking up large part of index. NVIDIA's success accounts for half of S&P 500's growth.

AMAT

2 minute read

What’s Going On With Taysha Gene Therapies Stock Tuesday?

By Vandana Singh

June 18, 11:42 AM

Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome.

TSHA

2 minute read

Top Trader Went All-In On Altcoins Only To See Them Crash: ‘This Is The Time That You’d Want To Risk More’

By Khyathi Dalal

June 18, 11:41 AM

Crypto analyst Michaёl van de Poppe shared his experience of going all-in on altcoins a month ago, only to see them crash shortly after.

$FTM

2 minute read

Movers
News

What’s Going On With Greenwave Technology

By Erica Kollmann

June 18, 11:37 AM

Greenwave Technology Solutions shares are trading higher Tuesday after the company announced the completion of its recapitalization. Here's a look at what to know:

GWAV

1 minute read

Movers
News

What’s Going On With Mustang Bio Stock Tuesday?

By Dylan Berman

June 18, 11:34 AM

Mustang Bio announced Monday safety and efficacy data from its Phase 1/2 clinical trial of MB-106, a possible treatment for certain types of blood cancer.

MBIO